# Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC

> **NCT02488850** · NA · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 32 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Surgery
- **RADIATION:** SABR

## Key facts

- **NCT ID:** NCT02488850
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2022-04-05
- **Final completion:** 2022-04-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488850, "Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02488850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*